RELINE
Device
NUVASIVE, INC.
Total Payments
$28.6M
Transactions
7,378
Doctors
1,948
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $4.0M | 1,288 | 487 |
| 2023 | $2.1M | 1,196 | 379 |
| 2022 | $1.6M | 722 | 325 |
| 2021 | $1.5M | 643 | 333 |
| 2020 | $1.5M | 525 | 224 |
| 2019 | $4.1M | 1,027 | 445 |
| 2018 | $2.4M | 980 | 454 |
| 2017 | $11.5M | 997 | 434 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $26.8M | 363 | 93.7% |
| Consulting Fee | $1.0M | 407 | 3.6% |
| Food and Beverage | $303,690 | 5,278 | 1.1% |
| Travel and Lodging | $298,445 | 1,250 | 1.0% |
| Unspecified | $113,503 | 34 | 0.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $38,547 | 10 | 0.1% |
| Education | $4,381 | 24 | 0.0% |
| Gift | $857.53 | 6 | 0.0% |
| Entertainment | $310.09 | 6 | 0.0% |
Payments by Type
General
$28.5M
7,344 transactions
Research
$113,503
34 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Posterior Fixation in Trauma, Reconstructive, and Tumor Surgery of the Occipito-cervico-thoracic Spine | Globus Medical, Inc. | $39,453 | 1 |
| Retrospective chart review of the safety and performance of NuVasive Fenestrated Screws with Bone Cement for the treatment of patients with advanced stage tumors in the thoracic and/or lumbar spine | NuVasive, Inc. | $23,836 | 0 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Posterior Fixation in Trauma, Reconstructive, and Tumor Surgery of the Occipito-cervico-thoracic Spine | NuVasive, Inc. | $20,580 | 0 |
| PSF: MAGEC | NuVasive, Inc. | $16,800 | 0 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Posterior Fixation in Trauma, Reconstructive, and Tumor Surgery of the Occipito-cervico-thoracic Spine (Not yet recruiting) | NuVasive, Inc. | $3,655 | 0 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of the NuVasive ACP System for the Treatment of Patients With Pathologic Conditions of the Cervical Spine | Globus Medical, Inc. | $3,280 | 1 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Posterior Fixation in Trauma, Reconstructive, and Tumor Surgery of the Occipito-cervico-thoracic Spine (Not yet recruiting) | Globus Medical, Inc. | $3,149 | 0 |
| A prospective, multicenter study evaluating the safety and performance of posterior fixation in trauma, reconstructive, and tumor surgery of the occipito-cervico-thoracic spine. | Globus Medical, Inc. | $1,967 | 0 |
| A Prospective Multicenter Study Evaluating the Effect of Implant Material and/or Surface Structure on Progression of Fusion in XLIF Surgery | Globus Medical, Inc. | $783.00 | 0 |
Top Doctors Receiving Payments for RELINE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Neurological Surgery | Atlanta, GA | $7.4M | 68 |
| Robert Isaacs | Neurological Surgery | Durham, NC | $1.9M | 51 |
| , M.D | Orthopaedic Surgery of the Spine | Spokane, WA | $1.5M | 8 |
| , M.D | Orthopaedic Surgery | Oakbrook Terrace, IL | $1.5M | 36 |
| , MD | Neurological Surgery | Tampa, FL | $1.4M | 108 |
| , MD | Neurological Surgery | Chicago, IL | $1.3M | 35 |
| , M.D | Orthopaedic Surgery of the Spine | Durango, CO | $1.2M | 62 |
| , M.D | Specialist | La Jolla, CA | $1.1M | 13 |
| , MD | Orthopaedic Surgery | Durham, NC | $1.0M | 3 |
| , MD | Orthopaedic Surgery | San Francisco, CA | $953,243 | 22 |
| , MD | Orthopaedic Surgery | Palo Alto, CA | $945,981 | 7 |
| , M.D | Orthopaedic Surgery of the Spine | Boston, MA | $945,914 | 9 |
| , MD | Orthopaedic Surgery of the Spine | Medford, OR | $945,685 | 4 |
| , MD | Orthopaedic Surgery | Thousand Oaks, CA | $945,629 | 4 |
| , MD | Neurological Surgery | Charlottesville, VA | $942,285 | 55 |
| , M.D | Pediatric Orthopaedic Surgery | San Diego, CA | $516,548 | 73 |
| , MD | Neurological Surgery | Philadelphia, PA | $393,633 | 98 |
| , MD | Neurological Surgery | Chicago, IL | $330,854 | 13 |
| , MD | Orthopaedic Surgery | New York, NY | $322,014 | 11 |
| , M.D | Orthopaedic Surgery of the Spine | Carmel, IN | $308,784 | 9 |
| , M.D | Orthopaedic Surgery | Oklahoma City, OK | $280,424 | 97 |
| , M.D | Pediatric Orthopaedic Surgery | Los Angeles, CA | $225,055 | 91 |
| , MD | Orthopaedic Surgery of the Spine | Raleigh, NC | $216,796 | 16 |
| , M.D | Orthopaedic Surgery of the Spine | Santa Monica, CA | $168,414 | 15 |
| , M.D | Neurological Surgery | Laguna Hills, CA | $162,702 | 65 |
Ad
Manufacturing Companies
- NuVasive, Inc. $13.1M
- NUVASIVE, INC. $11.5M
- Globus Medical, Inc. $4.0M
Product Information
- Type Device
- Total Payments $28.6M
- Total Doctors 1,948
- Transactions 7,378
About RELINE
RELINE is a device associated with $28.6M in payments to 1,948 healthcare providers, recorded across 7,378 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $4.0M was paid across 1,288 transactions to 487 doctors.
The most common payment nature for RELINE is "Royalty or License" ($26.8M, 93.7% of total).
RELINE is associated with 9 research studies, including "A Prospective, Multicenter Study Evaluating the Safety and Performance of Posterior Fixation in Trauma, Reconstructive, and Tumor Surgery of the Occipito-cervico-thoracic Spine" ($39,453).